Biotech Announces ‘Late-Breaking’ Addition to Immunotherapy Conference – Streetwise Reports
Streetwise Reports |
Biotech Announces 'Late-Breaking' Addition to Immunotherapy Conference
Streetwise Reports An Oct. 12 research report noted that Infinity Pharmaceuticals Inc. (INFI:NASDAQ) announced "an IPI-549 late-breaking oral presentation" at the Society for Immunotherapy of Cancer's (SITC's) yearly conference next month." The presentation will … |
